Syngene International Share Price
Mid Cap | Pharmaceuticals and health care | NSE: SYNGENE | BSE: 539268
₹724.65 -22.50 (-3.01 %)
Last Updated: 04 Apr 2025 03:57 PM
Overview
Open (₹) 750.00
High (₹) 750.00
Low (₹) 709.55
Prev. Close (₹) 747.15
Volume 8,04,600
VWAP (₹) 657.74
ROCE (%) 13.56
Industry P/E 61.88
TTM P/E 58.16
P/B Ratio 6.84
Market Cap (₹) Cr.29,169.84
Dividend Yield (%)0.17
EPS (₹) 12.69
ROE11.98%
Sales Growth (%) 9.26
Profit Growth (%)9.82
Day Range
750.00750.00
52 Week Range
608.00960.00
Historical Returns
Returns (6M)
-16.64 %
Returns (1Y)
-0.66 %
Returns (3Y)
18.92 %
Returns (5Y)
165.34 %
Returns (6M)
-16.64 %
Returns (1Y)
-0.66 %
Returns (3Y)
18.92 %
Returns (5Y)
165.34 %
SWOT Analysis
- Company with (10.25%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 10.25% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 43.64
MFI 58.91
ATR 23.47
Commodity Channel Index -180.62
ROC125 -23.59
ROC21 -14.12
Williams %R -96.63
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 669.35 | 686.30 | 696.40 | 659.25 | 642.30 | 632.20 | 615.25 |
Week Ago | 724.96 | 736.18 | 746.36 | 714.78 | 703.56 | 693.38 | 682.16 |
Month Ago | 776.20 | 808.40 | 846.50 | 738.10 | 705.90 | 667.80 | 635.60 |
EMA & SMA
724.65
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
8
5 Day 695.67
9 Day 696.04
10 Day 693.65
12 Day 701.69
14 Day 705.71
20 Day 716.08
26 Day 730.05
50 Day 786.16
100 Day 833.43
200 Day 807.07
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹560.60 | 26,735 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹560.60 | 2,05,767 | NSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹560.60 | 26,735 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹560.60 | 2,05,767 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
27 Dec, 2024 | ANJAN CHAKRABARTI | Disposal | ₹850.59 | 6,190 | NSE |
23 Dec, 2024 | ANJAN CHAKRABARTI | Acquisition | ₹859.73 | 58,390 | NSE |
23 Dec, 2024 | ANJAN CHAKRABARTI | Disposal | ₹843.54 | 27,200 | NSE |
11 Dec, 2024 | BIOCON LIMITED | Disposal | ₹857.68 | 80,00,000 | NSE |
28 Nov, 2024 | DEEPAK VENKATRAMAN | Disposal | ₹889.35 | 600 | NSE |
28 Nov, 2024 | MAYANK VERMA | Disposal | ₹913.17 | 1,500 | NSE |
28 Nov, 2024 | DEEPAK VENKATRAMAN | Disposal | ₹907.15 | 600 | NSE |
18 Nov, 2024 | ALOK MEHROTRA | Disposal | ₹858.22 | 8,200 | NSE |
18 Nov, 2024 | ALOK MEHROTRA | Acquisition | ₹876.03 | 20,000 | NSE |
11 Nov, 2024 | SIBAJI BISWAS | Disposal | ₹913.64 | 35,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
24 Apr, 2024 | Rs.1.2500 per share(12.5%)Final Dividend | 28 Jun, 2024 | 28 Jun, 2024 |
26 Apr, 2023 | Rs.0.5000 per share(5%)Final Dividend | 30 Jun, 2023 | 30 Jun, 2023 |
28 Apr, 2022 | Rs.0.5000 per share(5%)Special Dividend | 30 Jun, 2022 | 01 Jul, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
01 Apr, 2025 | NSE India | SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
01 Apr, 2025 | NSE India | Syngene International Limited has informed the Exchange regarding ''Grant of Performance Share Units under Syngene Long-Term Incentive Performance Share Plan 2023 (""Plan""). |
01 Apr, 2025 | BSE India | Intimation of appointment of Mr. Peter Bains as an Additional Director, designated as Managing Director & Chief Executive Officer. |
01 Apr, 2025 | NSE India | Syngene International Limited has informed the Exchange regarding appointment of Mr. Peter Bains as an Additional Director, designated as Managing Director & CEO of the Company w.e.f. April 01, 2025. |
29 Mar, 2025 | BSE India | Intimation of an update on the tax litigations. |
29 Mar, 2025 | NSE India | Syngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company |
28 Mar, 2025 | NSE India | Syngene International Limited has informed the Exchange regarding ''Reminder - Communication to shareholders for claiming unclaimed dividends.''. |
28 Mar, 2025 | BSE India | Reminder - Communication to shareholders for claiming unclaimed dividends. |
28 Mar, 2025 | BSE India | Intimation of disclosure on receipt of order from the Income Tax Department. |
28 Mar, 2025 | NSE India | Syngene International Limited has informed the Exchange regarding ''Intimation of disclosure on receipt of order from the Income Tax Department.''. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 14 Jan, 2025 | 23 Jan, 2025 |
Quarterly Results | -- | 07 Oct, 2024 | 23 Oct, 2024 |
Quarterly Results | -- | 01 Jul, 2024 | 24 Jul, 2024 |
Audited Results & Final Dividend | -- | 02 Apr, 2024 | 24 Apr, 2024 |
Quarterly Results | -- | 27 Dec, 2023 | 25 Jan, 2024 |
Quarterly Results | -- | 10 Oct, 2023 | 17 Oct, 2023 |
Quarterly Results | -- | 14 Jul, 2023 | 26 Jul, 2023 |
Audited Results & Final Dividend | -- | 11 Apr, 2023 | 26 Apr, 2023 |
Quarterly Results | -- | 09 Jan, 2023 | 23 Jan, 2023 |
Quarterly Results | -- | 07 Oct, 2022 | 19 Oct, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 52.74% | 54.79% | 64.86% | 70.41% | 70.59% |
Foreign Institutions + | 20.65% | 21.2% | 16.87% | 13.82% | 14.29% |
Domestic Institutions + | 19.52% | 14.64% | 7.04% | 4.44% | 5.82% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 6.8% | 9.05% | 10.76% | 10.61% | 8.57% |
Others | 0.29% | 0.32% | 0.47% | 0.72% | 0.73% |
About Syngene International
Syngene International is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937. Currently Company is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 3203.10 Cr. and Equity Capital is Rs. 402.00 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Jonathan Hunt
NSE Symbol
SYNGENE
Syngene International Management
Name | Designation |
---|---|
Ms. Kiran Mazumdar Shaw | Non Executive Chairman |
Mr. Jonathan Hunt | Managing Director & CEO |
Mr. Sibaji Biswas | Executive Director & CFO |
Prof. Catherine Rosenberg | Non Executive Director |
Dr. Kush Parmar | Independent Director |
Mr. Paul Blackburn | Independent Director |
Ms. Sharmila Abhay Karve | Independent Director |
Dr. Vijay Kuchroo | Independent Director |
Mr. Nilanjan Roy | Independent Director |
Ms. Vinita Bali | Lead Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Syngene International | ₹29,169.84 | ₹724.65 ₹747.15(-3.01%) | ₹608.000 - ₹960.000 |
Sun Pharma Advanced Research Company | ₹4,723.09 | ₹145.54 ₹150.00(-2.97%) | ₹109.200 - ₹474.000 |
Suven Life Sciences | ₹2,807.04 | ₹128.72 ₹131.41(-2.05%) | ₹83.270 - ₹169.000 |
Vimta Labs | ₹2,055.47 | ₹924.45 ₹1,092.35(-15.37%) | ₹420.000 - ₹1,183.000 |
Choksi Laboratories | ₹82.82 | ₹118.90 ₹123.40(-3.65%) | ₹46.010 - ₹142.400 |
FAQs on Syngene International
What is the share price of Syngene International?
The share price of Syngene International on 04 Apr, 2025 is ₹ 724.65.
What is 52W high and 52W low share price of Syngene International?
The highest and lowest 52W share prices of Syngene International are ₹ 960.000 and ₹ 608.000
What is the market cap of Syngene International?
The market capitalization of Syngene International as of 04 Apr, 2025 is ₹ 29,169.84 Crores
What is the P/E ratio of Syngene International?
The current P/E ratio of Syngene International as of 04 Apr, 2025 is 61.88
What is the PB ratio of Syngene International?
The PB ratio of Syngene International as of 04 Apr, 2025 is 6.84
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)